摘要
It is well known that interferons are potential antivirus proteins and possess anticancer capability. In the Thirty-fifth Symposium of the Society for General Microbiology on Interferons held in 1983, Hans Strander reported that interferons had been successfully applied in the treatment of juvenile laryngeal papilloma, papilloma accuminatum, malignant mydomatosis, osteosarcoma, breast cancer, cancer of the colon, non-Hodgkin lymphoma,